|
|
| MRD / Regn No. |
: SG002988 |
Date |
: 25/06/2026 |
| Patient Name |
: G.S.Roy |
Age & Gender |
: 68 Yrs. / Female |
| Contact No. |
: 9433828297 |
UHID |
: |
| Ht / Wt / BMI |
: 148 / 56 / 25.57 |
BP S / BP D |
: 111 / 72 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (05/Nov/1997) | CKD 3A (05/Nov/2024) | HYPERTENSION (05/Nov/2024) | |
| Salient Investigations |
: |
POTASSIUM: 4.17 | CREATININE: 2.07 | EGFR EGLOMERULAR FILTRATION RATE: 25.52 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 182 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 6.9 % | MICROALBUMIN CREATININE RATIO: 87.3 mcg/mg |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
CILNIDIPINE 10 MG + TELMISARTAN 80 MG
CILACAR T 80/10 MG |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
2 |
ATORVASTATIN 10 MG
TONACT 10 MG |
PO |
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
3 |
TABLET FINERENONE 20 MG
LYVELSA 20 MG |
PO |
1-0-0 |
BEFORE BREAKFAST
|
|
|
|
4 |
INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL |
SQ |
0-0- 24 |
BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
5 |
ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
ZEXRIDA 10 |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
6 |
SEMAGLUTIDE 0.25 MG; 0.5 MG/DOSE)
OZEMPIC |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
7 |
GLICLAZIDE 80
GLIZID |
PO |
1-0-1 |
BEFORE BREAKFAST AND DINNER
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 25/Dec/2026 |
| Tests Suggested For Next Visit |
: CHECK UACR:SPOT SAMPLE AND SERUM POTASSIUM AFTER 4 WEKS AND INFORM,SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE,CREATININE |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |